2023
Vial-splitting and Repackaging into Aliquot-specific Syringes: A Cost-effective and Waste-decreasing Strategy for Sugammadex
Amaya S, Kalsotra S, Tram N, Tobias J, Olbrecht V. Vial-splitting and Repackaging into Aliquot-specific Syringes: A Cost-effective and Waste-decreasing Strategy for Sugammadex. Pediatric Quality And Safety 2023, 8: e646. PMID: 37051405, PMCID: PMC10085484, DOI: 10.1097/pq9.0000000000000646.Peer-Reviewed Original ResearchDose of sugammadexPediatric patientsTertiary care pediatric institutionWeight-based dosingPercentage of patientsPerioperative useQuality improvement studySugammadex administrationLow dosesElectronic medical recordsCost of sugammadexPediatric institutionPatientsMedical recordsSugammadexDoseStudy periodHealthcare centersImprovement studyVial sizeAverage costDecrease wasteAliquots
2022
Cardiovascular effects of hyoscine butylbromide in patients under general anaesthesia
Quintero C, Molano M, Amaya S, Maya J, Andrade M. Cardiovascular effects of hyoscine butylbromide in patients under general anaesthesia. Journal Of Perioperative Practice 2022, 33: 211-216. PMID: 35285310, DOI: 10.1177/17504589211072698.Peer-Reviewed Original ResearchConceptsHyoscine butylbromideGeneral anesthesiaCardiovascular effectsBlood pressureIntraoperative bradycardiaPerioperative riskHeart rateAdministration of hyoscine butylbromideEffect of hyoscine butylbromideDose-related cardiovascular effectsBlood pressure of patientsPressure of patientsMicrosoft Excel databaseRetrospective studyAverage doseOutpatient basisElective surgeryArterial pressurePatientsButylbromideAnesthesiaBloodBradycardiaHeartDose